Featured Research

from universities, journals, and other organizations

Prenatal exposure to pesticide DDT linked to adult high blood pressure

Date:
March 12, 2013
Source:
University of California - Davis
Summary:
Infant girls exposed to high levels of the pesticide DDT while still inside the womb are three times more likely to develop hypertension when they become adults, according to a new study.

Infant girls exposed to high levels of the pesticide DDT while still inside the womb are three times more likely to develop hypertension when they become adults, according to a new study led by the University of California, Davis.

Previous studies have shown that adults exposed to DDT (dichlorodiplhenyltrichloroethane) are at an increased risk of high blood pressure. But this study, published online March 12 in Environmental Health Perspectives, is the first to link prenatal DDT exposure to hypertension in adults.

Hypertension, or high blood pressure, is a high risk factor for heart disease, which remains the leading cause of death in the United States and worldwide.

"The prenatal period is exquisitely sensitive to environmental disturbance because that's when the tissues are developing," said study lead author Michele La Merrill, an assistant professor in the UC Davis Department of Environmental Toxicology.

The U.S. Environmental Protection Agency banned DDT in this country in 1972 after nearly three decades of use. However, the pesticide is still used for malaria control in other parts of the world, such as India and South Africa. That means children born in those areas could have a higher risk of hypertension as adults.

La Merrill said that traces of DDT, a persistent organic pollutant, also remain in the food system, primarily in fatty animal products.

The study examined concentrations of DDT in blood samples collected from women who had participated in the Child Health and Development Studies, an ongoing project of the nonprofit Public Health Institute. The CHDS recruited women who sought obstetric care through Kaiser Permanente Foundation Health Plan in the San Francisco Bay Area between 1959 and 1967. They also surveyed the adult daughters of those women to learn if they had developed hypertension.

"Evidence from our study shows that women born in the U.S. before DDT was banned have an increased risk of hypertension that might be explained by increased DDT exposure," said La Merrill. "And the children of people in areas where DDT is still used may have an increased risk, as well."


Story Source:

The above story is based on materials provided by University of California - Davis. Note: Materials may be edited for content and length.


Journal Reference:

  1. Michele La Merrill, Piera M. Cirillo, Mary Beth Terry, Nickilou Y. Krigbaum, Julie D. Flom, Barbara A. Cohn. Prenatal Exposure to the Pesticide DDT and Hypertension Diagnosed in Women Before Age 50: A Longitudinal Birth Cohort Study. Environmental Health Perspectives, 2013; DOI: 10.1289/ehp.1205921

Cite This Page:

University of California - Davis. "Prenatal exposure to pesticide DDT linked to adult high blood pressure." ScienceDaily. ScienceDaily, 12 March 2013. <www.sciencedaily.com/releases/2013/03/130312092646.htm>.
University of California - Davis. (2013, March 12). Prenatal exposure to pesticide DDT linked to adult high blood pressure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/03/130312092646.htm
University of California - Davis. "Prenatal exposure to pesticide DDT linked to adult high blood pressure." ScienceDaily. www.sciencedaily.com/releases/2013/03/130312092646.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins